Persicaria minor (kesum)
Also called Polygonum minus, kesum, Biokesum, LineMinus.
Best grade D across 1 graded outcome Botanical Last checked
The short answer
From 7 sourcesPersicaria minor, called kesum in Malaysia, is a cooking herb sold as a standardized water extract. One small six-month placebo-controlled trial in 36 older adults with mild cognitive impairment, funded by the extract's maker, found better visual memory and mood scores. An earlier trial in middle-aged women was retracted. Evidence is preliminary.
Every graded outcome on this page
1 row · line = participantsKey facts
- Only valid trial
- 36 adults aged 60-75 with mild cognitive impairment, 250 mg extract twice daily vs placebo for 6 months; 30 finished1
- What changed
- Visual Reproduction II memory scores, tension, anger and confusion improved vs placebo; MMSE, digit span and verbal learning did not1
- Retracted study
- A 2015 six-week trial of the extract in 35 middle-aged women was retracted by the journal in 201723
- Industry funding
- The 2020 trial was funded by Biotropics Malaysia, the maker of the Biokesum extract, which was also responsible for study design1
- Agency safety reviews
- No ODS, NCCIH, LactMed, LiverTox, Health Canada or EMA monograph covers this herb4
What it is
Persicaria minor (kesum) is a Malaysian culinary herb sold as a water extract for memory and mood support.
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Persicaria minor (kesum) forms compared
2 forms| 2 forms | Standardized water extract capsules (e.g., Biokesum) | Fresh leaves (cooking herb) |
|---|---|---|
| Absorption in people | No head-to-head human data1 | Not studied.5 |
| GI tolerance | No adverse events were reported over 6 months in the 36-person trial.1 | Widely used as a flavoring herb in cooking; amounts in food are far lower than extract doses and have not been studied as a supplement.5 |
| Studied for | Memory and mood in older adults with mild cognitive impairment | No human trials of the whole leaf |
- Standardized water extract capsules (e.g., Biokesum)
- Fresh leaves (cooking herb)
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
1 graded outcome, largest study firstOne graded outcome so far. Visual memory and mood in older adults with mild cognitive impairment: a 2020 randomized trial of 36 people found an improvement.
Bar: the ages a study enrolled (running to the edge when it states no upper or lower limit). Dot: only a mean age, counted as near your age within 5 years. Tick: the mean age inside a range.
1Visual memory and mood in older adults with mild cognitive impairment: improved, 60–75
1Visual memory and mood in older adults with mild cognitive impairment
Improved · Grade D · RCT, 36 people, 2020
Malaysian community-dwelling adults aged 60-75 with mild cognitive impairment
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Visual memory and mood in older adults with mild cognitive impairment | Improved | 36 | Grade D · RCT, 2020 | Malaysian community-dwelling adults aged 60-75 with mild cognitive impairment |
Every graded row
1 rowDGrade DVisual memory and mood in older adults with mild cognitive impairmentMemory and moodSmall gains on some testsRCT
n 36 · 2020
Improved Visual Reproduction II scores, tension, anger, confusion and total negative mood improved vs placebo, as did BDNF and triglycerides. Other memory tests (MMSE, digit span, verbal learning, digit symbol) did not differ. 30 of 36 finished; brain-scan findings in 15 people were labelled preliminary.
- Design
- RCT, n = 36, 2020
- Population
- Malaysian community-dwelling adults aged 60-75 with mild cognitive impairment
- Form
- Biokesum water extract of P. minor (250 mg capsules)
- Dose
- 250 mg twice daily (500 mg/day)
- Duration
- 6 months
- Source
- Reference 1 · PubMed 33076878 (opens PubMed)
Lab and animal research (preclinical)
2 notesNone of this has been shown in people.
- Genotoxicity tests (lab)
- The Biokesum extract was negative in three standard OECD guideline genotoxicity tests (a bacterial mutation test, a chromosomal aberration test and a micronucleus test). These lab tests do not show safety in people at supplement doses.7
- Memory in rats
- In rats with chronically reduced brain blood flow, Persicaria minor improved cognitive function.6
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Doses studied in human trials ranged from 250 mg of water extract twice a day (500 mg/day) for 6 months in the only non-retracted placebo-controlled trial. These are research doses, not recommendations.1
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Persicaria minor and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Persicaria minor.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Pregnancy and breastfeeding
- No agency monograph covers kesum extract. NCCIH notes that many dietary supplements have not been tested in pregnant or nursing women, and no trial of this extract enrolled them.4
- People on medicines
- No drug-interaction data were found in ODS, NCCIH, LactMed, LiverTox, Health Canada or EMA sources. NCCIH advises telling your health care providers about any supplement, since supplements can interact with medicines.4
- Before surgery
- NCCIH notes that some supplements can raise bleeding risk or affect anesthesia, and advises telling the surgical team about every supplement in advance.4
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
5 answersDoes Persicaria minor improve memory?
One small six-month trial in older adults with mild cognitive impairment found better scores on one visual memory test but not on the other memory tests. It was funded by the extract maker, and no independent trial has repeated it.1
Is it safe?
What dose was studied?
250 mg of the Biokesum water extract twice a day for 6 months.1
Is kesum the same as Polygonum minus?
Sources
7 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
7 sources- 1The effects of six months Persicaria minor extract supplement among older adults with mild cognitive impairment: a double-blinded, randomized, and placebo-controlled trial.RCT BMC Complement Med Ther, 2020 · PMID 33076878
- 2The effect of Polygonum minus extract on cognitive and psychosocial parameters according to mood status among middle-aged women: a randomized, double-blind, placebo-controlled study (RETRACTED).RCT Clin Interv Aging, 2015 · PMID 26445532
- 3The effect of Polygonum minus extract on cognitive and psychosocial parameters according to mood status among middle-aged women: a randomized, double-blind, placebo-controlled study [Retraction].Safety communication Clin Interv Aging, 2017 · PMID 29062226
- 4Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
- 5Antioxidative and anti-inflammatory activities of Polygonum minus: a review of literature.Review Rev Cardiovasc Med, 2020 · PMID 32706215
- 6Persicaria minor ameliorates the cognitive function of chronic cerebral hypoperfusion rats: Metabolomic analysis and potential mechanisms.Animal study Behav Brain Res, 2023 · PMID 37030545
- 7Genotoxicity Evaluation of Biokesum® Polygonum minus (Persicaria Minor) Standardized Extract Using Bacterial Reverse Mutation, In Vitro Micronucleus, and In Vitro Chromosomal Aberration Studies.Lab study J Med Food, 2025 · PMID 40518833
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| research notes | Searched PubMed (Persicaria minor, Polygonum minus, kesum, Biokesum) through 2026: no new human trial or meta-analysis; the 2020 trial (PMID 33076878) remains the only valid human trial. Added a 2025 lab genotoxicity study of the extract (PMID 40518833) to research notes, labelled as lab data. No ODS, NCCIH, LactMed, or LiverTox source covers this herb; interaction data remain absent, as the existing notes say. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| all | Initial editorial evidence review | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.